Shigematsu H - Search Results

1

Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers.

Shigematsu H, Gazdar AF. Shigematsu H, et al. Int J Cancer. 2006 Jan 15;118(2):257-62. doi: 10.1002/ijc.21496. Int J Cancer. 2006. PMID: 16231326 Free article. Review.

2

Aberrant methylation of SPARC in human lung cancers.

Suzuki M, Hao C, Takahashi T, Shigematsu H, Shivapurkar N, Sathyanarayana UG, Iizasa T, Fujisawa T, Hiroshima K, Gazdar AF. Suzuki M, et al. Among authors: shigematsu h. Br J Cancer. 2005 Mar 14;92(5):942-8. doi: 10.1038/sj.bjc.6602376. Br J Cancer. 2005. PMID: 15756262 Free PMC article. Retracted.

3

DNA methylation-associated inactivation of TGFbeta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers.

Suzuki M, Shigematsu H, Shames DS, Sunaga N, Takahashi T, Shivapurkar N, Iizasa T, Frenkel EP, Minna JD, Fujisawa T, Gazdar AF. Suzuki M, et al. Among authors: shigematsu h. Br J Cancer. 2005 Oct 31;93(9):1029-37. doi: 10.1038/sj.bjc.6602837. Br J Cancer. 2005. PMID: 16234815 Free PMC article. Retracted.

4

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types.

Shivapurkar N, Toyooka S, Toyooka KO, Reddy J, Miyajima K, Suzuki M, Shigematsu H, Takahashi T, Parikh G, Pass HI, Chaudhary PM, Gazdar AF. Shivapurkar N, et al. Among authors: shigematsu h. Int J Cancer. 2004 May 1;109(5):786-92. doi: 10.1002/ijc.20041. Int J Cancer. 2004. PMID: 14999791 Free article.

5

Molecular targets for cancer therapy and prevention.

Gazdar AF, Miyajima K, Reddy J, Sathyanarayana UG, Shigematsu H, Suzuki M, Takahashi T, Shivapurkar N. Gazdar AF, et al. Among authors: shigematsu h. Chest. 2004 May;125(5 Suppl):97S-101S. doi: 10.1378/chest.125.5_suppl.97s-a. Chest. 2004. PMID: 15136434 Review.

6

Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis.

Takahashi T, Shivapurkar N, Riquelme E, Shigematsu H, Reddy J, Suzuki M, Miyajima K, Zhou X, Bekele BN, Gazdar AF, Wistuba II. Takahashi T, et al. Among authors: shigematsu h. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6126-33. doi: 10.1158/1078-0432.CCR-04-0579. Clin Cancer Res. 2004. PMID: 15447999

7

Mutations and addiction to EGFR: the Achilles 'heal' of lung cancers?

Gazdar AF, Shigematsu H, Herz J, Minna JD. Gazdar AF, et al. Among authors: shigematsu h. Trends Mol Med. 2004 Oct;10(10):481-6. doi: 10.1016/j.molmed.2004.08.008. Trends Mol Med. 2004. PMID: 15464447 Review.

8

Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies.

Shigematsu H, Suzuki M, Takahashi T, Miyajima K, Toyooka S, Shivapurkar N, Tomlinson GE, Mastrangelo D, Pass HI, Brambilla E, Sathyanarayana UG, Czerniak B, Fujisawa T, Shimizu N, Gazdar AF. Shigematsu H, et al. Int J Cancer. 2005 Feb 10;113(4):600-4. doi: 10.1002/ijc.20622. Int J Cancer. 2005. PMID: 15472908 Free article.

9

Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer.

Amann J, Kalyankrishna S, Massion PP, Ohm JE, Girard L, Shigematsu H, Peyton M, Juroske D, Huang Y, Stuart Salmon J, Kim YH, Pollack JR, Yanagisawa K, Gazdar A, Minna JD, Kurie JM, Carbone DP. Amann J, et al. Among authors: shigematsu h. Cancer Res. 2005 Jan 1;65(1):226-35. Cancer Res. 2005. PMID: 15665299

10

Aberrant methylation of Reprimo in human malignancies.

Takahashi T, Suzuki M, Shigematsu H, Shivapurkar N, Echebiri C, Nomura M, Stastny V, Augustus M, Wu CW, Wistuba II, Meltzer SJ, Gazdar AF. Takahashi T, et al. Among authors: shigematsu h. Int J Cancer. 2005 Jul 1;115(4):503-10. doi: 10.1002/ijc.20910. Int J Cancer. 2005. PMID: 15700311 Free article. Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

852 results

Search Page